Physician

Mohammed Y Pathan, MD

According to 2025 Medicare claims, Mohammed Pathan, MD (NPI: 1073575288) practices neurology in the Columbus, GA-AL market, with the plurality of this provider's patient population coming from Muscogee, GA. This provider's primary affiliated billing organization is RIVER CITY NEUROLOGICAL ASSOCIATES (NPI: 1790101392; TIN: 46-4236116) and primary practice location at 31904-8806.

Pathan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,100 traditional Medicare patients, billed 47,708 HCPCS/CPT codes, and received $502,073 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 8,401 prescription claims across 1,010 beneficiaries totaling $3,415,270 in drug costs, led by Vumerity (Diroximel Fumarate). DME data shows 246 claims. Open Payments data shows 97 records totaling $1,991. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $93,218 to $502,073. Similarly, Part D prescription costs have moved sharply higher in recent years, from $264,668 to $3,415,270. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $4,346 and ending at $16,034.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	439	999	$93,218
2016	456	1,027	$99,177
2017	654	2,265	$156,653
2018	788	10,087	$193,683
2019	907	18,169	$437,140
2020	954	17,945	$405,435
2021	1,171	24,829	$450,130
2022	1,120	53,854	$857,456
2023	1,125	56,617	$749,758
2024	1,100	47,708	$502,073

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	167	942	$264,668
2016	211	1,532	$355,472
2017	287	2,003	$687,690
2018	378	3,212	$853,296
2019	444	3,882	$1,478,664
2020	493	4,072	$1,538,372
2021	598	4,673	$2,062,760
2022	727	5,935	$2,540,125
2023	886	7,218	$3,055,809
2024	1,010	8,401	$3,415,270

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$810
2016	N/R	29	$1,016
2017	N/R	44	$995
2018	N/R	83	$1,675
2019	N/R	38	$787
2020	N/R	84	$4,314
2021	22	188	$9,585
2022	39	118	$4,736
2023	47	210	$8,412
2024	37	246	$12,350

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	78	79	$146
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	218	218	$144
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	159	160	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	758	1,442	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	92	95	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vumerity	Diroximel Fumarate	41	1,230	$344,583
Tysabri	Natalizumab	37	1,148	$321,352
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	16	644	$310,418
Kesimpta Pen	Ofatumumab	19	720	$210,106
Emgality Pen	Galcanezumab-Gnlm	157	6,964	$162,525

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
K0823	Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	19	$2,752
E1161	Manual adult size wheelchair, includes tilt in space	Y	N/R	11	$2,011
A7031	Face mask interface, replacement for full face mask, each	N	N/R	23	$1,505
A7030	Full face mask used with positive airway pressure device, each	N	N/R	23	$1,472
K0814	Power wheelchair, group 1 standard, portable, captains chair, patient weight capacity up to and including 300 pounds	Y	N/R	12	$1,467

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$1,991	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammed Y. Pathan, MD?

Tedicare shows public-source Medicare data for Mohammed Y. Pathan, MD (NPI 1073575288), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed Y. Pathan, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohammed Y. Pathan, MD?

Mohammed Y. Pathan, MD is linked to RIVER CITY NEUROLOGICAL ASSOCIATES (billing NPI 1790101392) in the available physician profile data.

Does Mohammed Y. Pathan, MD have Open Payments data?

Mohammed Y. Pathan, MD has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.